Bryce Point Capital, LLC
- SEC CIK
- 0002019492
- Latest filing
- Nov 6, 2025
NAMS holding history
NewAmsterdam Pharma Co N.V. in every 13F filed by Bryce Point Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NAMS overviewAll 13F holders of NAMSFull Q3 2025 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q1 2025